About Cylex
Cylex is a Healthcare company based in Columbia (United States) founded in 1992, and was acquired by Viracor-IBT Laboratories in February 2013. In vitro diagnostic assays for immune function monitoring are developed. Cylex has raised $42.2 million across 3 funding rounds from investors including Roche, Canaan and Calvert. Its focus areas include Diversified Diagnostics.
Company details
In vitro diagnostic products are developed by Cylex, founded in 1992 and based in Columbia, United States, within the biotechnology sector. The ImmuKnow assay is provided to assess cell-mediated immune responses in organ transplant patients on immunosuppressive therapy. Additional assays for diseases and companion diagnostics targeting immune-affecting treatments are enabled by its technology. Operations as a subsidiary of ViraCor-IBT have been maintained since 2013.
- Headquarters Columbia, United States
- Stage Acquired
- SectorsHealthcare
- Website cylex.net
- Social LinkedIn
- Acquired by Viracor-IBT Laboratories (Feb 2013)
- Total Equity Funding$42.2M (USD)
in 3 rounds
- Latest Funding Round$3.3M (USD), Series C
Aug 2010
- InvestorsRoche
& 9 more
- Acquired byViracor-IBT Laboratories
(Feb 2013)
Funding Insights of Cylex
Cylex has successfully raised a total of $42.2M across 3 strategic funding rounds. The most recent funding activity was a Series C round of $3.3 million completed in August 2010. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding $42.2M
- Total Rounds 3
- Last Round Series C — $3.3M
- First Round $18.4M
(Dec 2006)
- Investors Count 9
All 3 funding rounds of Cylex with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Aug 2010 | $3.3M | Series C | – | – | – |
| Mar 2007 | $20.5M | Series C | – | – | |
| Dec 2006 | $18.4M | Series B | – | – |
10 investors in total: 10 institutional.
Investors in Cylex
Cylex has secured backing from 10 investors, including institutional and venture fund investors. Prominent investors backing the company include Roche, Canaan and Calvert.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
| chanmed.com | ||||
Canaan is recognized as an early-stage venture capital firm. | 1987 | canaan.com | San Francisco, United States | |
Venture capital investments are managed from Kansas City. | 1976 | calvert.com | Kansas City, United States | |
Venture capital and transaction advisory services for B2B tech companies. | firstanalysis.com | |||
Early-stage venture capital investments are focused on US companies. | njtcvc.com | Mount Laurel Township, United States | ||
| cahnmedicalventures.com | ||||
Pharmaceuticals and diagnostics kits are developed for various diseases. | 1896 | roche.com | Basel, Switzerland | |
Operates a hedge fund focused on secondary market investments. | chesapeakepartners.net | Bethesda, United States | ||
| techunited.co | ||||
Diagnostic pathology services are provided by a standalone laboratory center. | 2000 | viracoribt.com | Lee's Summit, United States |
Investor details for Cylex
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
Timeline of Cylex
4 dated milestones of Cylex across 21 years, from founding to its latest funding, stage changes and deals.
- Founded Cylex is founded.
- Funding First funding round of $18.4M.
- Funding Latest funding round, Series C, of $3.3M.
- Exit Acquired by Viracor-IBT Laboratories.
Web traffic of Cylex
Websites that share an audience with Cylex (cylex.net).
Websites whose visitors overlap most with Cylex. Affinity shows how closely the audiences match.
| Website | Domain | Audience affinity | Monthly visits | Global rank | Profile |
|---|---|---|---|---|---|
| gracelaboratories.com | 100% | View details | |||
| trinitybiotech.com | 100% | 9.3K | #2,475,266 | View details | |
| eylabs.com | 100% | #5,913,034 | View details | ||
| seralab.co.uk | 100% | View details | |||
dutch-diagnostics.com | dutch-diagnostics.com | 100% | – | ||
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
All 21 similar websites and full traffic analytics for Cylex
The complete similar-websites list, audience overlap and engagement analytics require an active premium plan.
- 21 similar websites
- Audience overlap
- Engagement analytics
- Traffic by brand
Verified entity values are shown only after access is granted.
Top companies in Diagnostics & Lab Tech
3 companies that operate in the same segment as Cylex (Diagnostics & Lab Tech) in United States, ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
At-home health tests for biomarkers, nutrition, and hormone analysis. | 2014 | Austin, Texas, United States | USD 330 M | 336 | ||
Blood testing services are offered using finger-prick microsamples. | 2017 | Austin, Texas, United States | USD 37.7 M | |||
Manufactures clinical diagnostic test kits | 1971 | Irvine, California, United States | USD 4.45 M | 54 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Related news about Cylex
Complete news archive for Cylex
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Cylex
Cylex was founded in 1992 and raised its 1st funding round 14 years after it was founded.
Cylex is headquartered in Columbia, United States.
Cylex is a funded company, having raised a total of $42.2M across 3 funding rounds to date. The company's 1st funding round was a Series B of $18.4M, raised on Dec 2006.
In vitro diagnostic products are developed by Cylex, founded in 1992 and based in Columbia, United States, within the biotechnology sector. The ImmuKnow assay is provided to assess cell-mediated immune responses in organ transplant patients on immunosuppressive therapy. Additional assays for diseases and companion diagnostics targeting immune-affecting treatments are enabled by its technology. Operations as a subsidiary of ViraCor-IBT have been maintained since 2013.
Cylex has 10 investors. Key investors include Roche, Canaan, Calvert, Viracor-IBT Laboratories, and Channel Medical Partners.
Yes. Cylex was acquired by Viracor-IBT Laboratories in February 2013.